Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lipella Pharmaceuticals Inc
LIPO
Healthcare
Biotechnology
Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. The Company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The Company is addressing two indications via the development of its product candidates, which it has designated as LP-10 for the indication of hemorrhagic...
cystitis (HC) and LP-310 for the indication of oral lichen planus (OLP), which is chronic, uncontrolled urinary blood loss that results from certain chemotherapies (such as alkylating agents) or pelvic radiation therapy (also called radiation cystitis). In the third program, the Company is also developing an oral, liposomal formulation of tacrolimus, LP-410, for the treatment of oral graft-versus-host disease (GVHD). In a fourth program, the Company is also developing an intravesical formulation of immunoglobulins including checkpoint inhibitors, referred to as LP-50.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LIPO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(214)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 11, 2025 8:01am
Buy buddy buy because it's taking off this morning.
And furthermore,you fellas should be on-board already.
(214)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 06, 2025 9:27am
Great stock performance this morning.Wow.
Well guys,this stock is going to be giving shareholders big,or massive profit for me,after the big news came out. So that the early birds will be well rewarded today.Wow.
Largest Integrated Facility Services Provider in Canada Releases Financial Results for Q1, 2025
posted May 11, 2025 9:00am by
GDI Integrated Facility Services Inc.
-
|
Adjusted EBITDA* amounted to $34 million, representing an Adjusted EBITDA* margin of 6% compared to $28 million and 4% in Q1 2024. Net income was $6 million or $0.26 per share compared to $0.4 million or $0.02 per share in Q1 2024.Long-term debt, net of cash* decreased by $14 million in the quarter ...read more
(214)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Feb 06, 2025 7:46am
Buy buddy buy because this stock is going to be
Taking off to the upside today.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 27, 2024 8:00am
New Press Release - Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
Company has two lead drug candidates for rare disease indications in IND approved phase 2 clinical trials using the 505(b)(2) pathway PITTSBURGH, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 22, 2024 5:00am
New Press Release - Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research
Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth No FDA-approved therapy currently exists for OLPPatient registry and OLP study information is now available PITTSBURGH, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Lipella...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 21, 2024 5:00am
New Press Release - Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancerNovel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and Kidney Diseases5th International Consultation on Interstitial Cystitis Japan runs Aug. 21-23 in Kyoto...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 12, 2024 5:00am
New Press Release - Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
Top Line Data Expected Year-End 2024 PITTSBURGH, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces the...
read article.
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 1:53am
Lipella Pharmaceuticals Inc. (NASDAQ:LIPO): Reformulating Ge
https://beyondspx.com/2024/08/02/lipella-pharmaceuticals-inc-nasdaqlipo-reformulating-generic-drugs-for-new-applications/
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 01, 2024 4:05pm
New Press Release - Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
PITTSBURGH, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has closed its previously announced registered direct...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 01, 2024 8:00am
New Press Release - Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
PITTSBURGH, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has entered into a definitive agreement for the...
read article.
(103)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 31, 2024 12:39pm
RE:LIPO.....3 mins til opening bell
Live and learn Chasers!!!!!!!!!!!!!!!!!!
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 29, 2024 10:25am
LIPO....N.L.O.D...now at $0.9255
How do u like me so far ?????
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 29, 2024 10:18am
LIPO....sub $1 now
say goodnight sweet sharlet
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 29, 2024 10:13am
LIPO...Halt #2.....locked at $1
should resume in 2 mins I will say it now..... You've all been had.....AGAIN !!!!!
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 29, 2024 9:51am
LIPO....N.L.O.D
$1.08
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >